--- canonical_url: https://www.stockexpertai.com/earnings/tt last_updated: 2026-08-05T06:15:47.577Z --- # Trane Technologies plc (TT) Q1 FY2027 Earnings Preview > This content was automatically generated with FMP live data + Q2 FY2026 earnings call transcript. Generated: 2026-08-05T06:15:45.605Z. Educational tool, not investment advice. --- ## Quick Summary | Field | Value | Source | |---|---|---| | Price | $472.24 (▲ 2.39%) | fmp:quote | | Market Cap | $103.9B | fmp:profile | | 52w range | $348.06 – $505.87 | fmp:quote | | Earnings | Thu 29 Oct | fmp:earnings-history | | EPS estimate | $4.64 (+20% YoY) | fmp:earnings-estimate | | Revenue estimate | $6.5B | fmp:earnings-estimate | | Beat streak | 8/4 | fmp:earnings-history | | Rating | B (overall 3/5) | fmp:ratings | | Analyst median target | $555 (+17.5% upside) | fmp:price-target-consensus | | MoonshotScore | 51/100 | derived | | Council | 3/6 bullish | derived | | Munger verdict | Fairly Valued | derived | ## Trane Technologies plc — Q1 FY2027 Expectations Q1 consensus: revenue $6.5B^{[FMP est]}, EPS $4.64^{[FMP est]}. Christopher Kuehn lowered Commercial HVAC guidance to 10-10% (previous 9%) in the Q2 earnings call^{[Christopher Kuehn Q-prev transcript]}. 8 consecutive quarters of beat^{[FMP earnings]}. ## Quick Take **Score:** B · **Stance:** BUY · **Council:** 3/6 · **Moonshot:** 51 = MoonshotScore 51^{[multi-pillar formula]} + Council 3/6^{[6-lens rule]}. Commercial HVAC guidance reduction from 9% → 10-10%^{[Christopher Kuehn Q-prev transcript]} and the current Form 4 signal (0 transactions)^{[FMP Form 4]} prevented an A- grade. ## Watchlist (6 metrics) ### 1. Commercial Hvac Growth Americas Commercial HVAC bookings reached an all-time high, up 50% year-over-year, with broad-based growth across 11 of 14 verticals, including double-digit growth in most of them, beyond just data centers. > "Our commercial HVAC businesses delivered outstanding performance, particularly in the Americas, where bookings reached an all-time high up 50% year-over-year. ... we track 14 different verticals. They were all very strong. They were all up in fact, they were all of them up over 20%. But it's probably more constructive to look year-to-date -- and year-to-date, we had growth in 11 of 14 verticals from an order standpoint. And most of those 11 were double-digit growth." > — David Regnery, Chair and CEO, Investor Focus · Q2 FY2026 ### 2. Capital Allocation Capex Trane Technologies maintains a balanced capital allocation strategy with a target deployment of $2.8 billion to $3.3 billion for 2026, which includes expected CapEx of 2% to 3% of revenue. > "We remain on track with our balanced capital allocation strategy with a target deployment of $2.8 billion to $3.3 billion for the year. ... We continue to pursue disciplined M&A and are strategically investing in capacity to support future growth. with expected CapEx of 2% to 3% of revenue in 2026." > — Christopher Kuehn, Executive Vice President and CFO, Risk Indicator · Q2 FY2026 ### 3. Full Year Guidance Raise The company is raising its full year organic revenue growth outlook to approximately 9% and adjusted EPS guidance to a range of $15.20 to $15.30, reflecting strong execution and market dynamics. > "For the full year, we are again raising our guidance. This reflects the market dynamics and investment priorities we've discussed and consistent strong execution of our value creation flywheel. We are increasing our full year organic revenue growth outlook to approximately 9% and our adjusted EPS guidance to a range of $15.20 to $15.30." > — Christopher Kuehn, Executive Vice President and CFO, Expectation / Guide · Q2 FY2026 ### 4. Capacity Supply Chain The company has expanded its applied capacity 4x over the last 3 years and continues brick-and-mortar investments to meet increasing demand, actively managing supply chain constraints through robust processes and partner collaboration. > "Look, we have about $6 billion of the backlog, that's for 2027, as I said earlier. So that's going to give us a lot of momentum going into next year. We're not turning away orders, okay? We kind of I think I mentioned probably 2 quarters ago, we've expanded our applied capacity 4x over the last 3 years. That expansion continues to happen. So we have several -- first of all, we deploy our lean principles. So we're always looking to do more with what we have. But with that said, we also have brick-and-mortar investments that we're making -- we talked about Scalar already. We also have in Grand Rapids, we're making some investments. So look, that's going to continue. We're in front of that. So I feel like we're in a good spot there from a -- do we have enough capacity for the orders that are out there. And bring on if you have any orders and then just bring them out." > — David Regnery, Chair and CEO, Investor Focus · Q2 FY2026 ### 5. Record Backlog Visibility The company expects accelerating revenue in the second half of 2026 and a strong foundation for 2027 and beyond, with a record backlog of $12.1 billion, up 70%, and $6 billion slated for future years. > "Enterprise organic bookings were up 37%, driving record backlog of $12.1 billion, up 70% year-over-year. Our exceptional bookings, record backlog and healthy pipeline provides strong visibility to accelerating revenue in the second half. Our historic backlog also lays a strong foundation for continued market outperformance in the future. with approximately $6 billion slated for 2027 and beyond." > — David Regnery, Chair and CEO, Investor Focus · Q2 FY2026 ### 6. Americas Transport Recovery The Americas transport market is expected to improve in late 2026, leading into a multiyear up cycle, transitioning from a headwind to a healthy growth contributor for the company's portfolio. > "Following a prolonged downturn, we see the Americas transport market improving in late 2026 leading into a multiyear up cycle. Our internal outlook is directionally aligned with ACT, but assumes a more gradual slope of recovery. This reflects a more realistic pace for trailer OEMs to ramp capacity, a dynamic that has historically extended the duration of the up cycle. Having managed the down cycle effectively, while outperforming the markets. We look forward to this business transitioning from a headwind to a healthy growth contributor for our portfolio." > — David Regnery, Chair and CEO, Investor Focus · Q2 FY2026 ## MoonshotScore Pillars | Pillar | Score | Level | Evidence | |---|---|---|---| | Revenue Growth | 5.0 | medium | Q2 vs Q3: healthy growth (+10.6%) | | Gross Margin | 4.0 | medium | Q2: average margin (35.6%) | | Operating Leverage | 2.0 | weak | op margin healthy (19.3%) | | Cash Runway | 10.0 | strong | FCF very strong ($1.2B, 15.0× CapEx) | | R&D Intensity | 3.0 | weak | low R&D investment (0.0%, weak innovation) | | Price Momentum | 7.0 | strong | RSI 51.3 balanced, 50d above | | News Sentiment | 5.0 | medium | majority buy (54%) | **Formula:** sum(pillar.score) / (count * 10) * 100. Each pillar deterministic from FMP. Source maps in pillar.formula. ## Council (7-Lens) | Name | Stance | Context | |---|---|---| | Ray Dalio | bull | macro · target upside +17.5% | | Ken Griffin | bull | flow · 50d MA above | | Jim Simons | neutral | quant · RSI 51 | | Klarman | neutral | value · target upside +17.5% | | Buffett | bull | quality · ROE score 5/5 | | Munger | neutral | valuation · target upside +17.5% | **Formula:** Each lens uses deterministic rule on bundle data. Logged in member.contextTr. ## Munger Lens - **Verdict:** Fairly Valued - **Financial Health:** Moderate - **Margin of Safety:** Moderate - **Interest Coverage:** Adequate - **ROIC vs WACC:** Healthy **Formula:** verdict=upside>25?Undervalued:>0?Fairly Valued:Overvalued. Each lens deterministic from FMP ratings + priceTarget. ## Technical Levels - **RSI(14):** 51.3 — dengeli — yön sinyali zayıf - **50d MA:** $470 — hisse %0.4 üstünde — kısa vadeli destek - **200d MA:** $440 — hisse %7.3 üstünde — uzun vadeli destek - **Volume (10d):** -38% ## Past Performance (4 Quarters) | Quarter | EPS Actual | EPS Estimate | Result | Reaction | |---|---|---|---|---| | Q3 FY25 | $3.88 | $3.80 | BEAT | +0.5% | | Q4 FY25 | $2.86 | $2.81 | BEAT | -1.3% | | Q1 FY26 | $2.63 | $2.53 | BEAT | -1.2% | | Q2 FY26 | $4.31 | $4.27 | +0.9% EPS | +3.3% | Q2 (July 30, 2026): EPS $4.31 vs $4.27 est^[FMP], +0.9% beat. D+1 movement: +3.3%^{[FMP D+1]}. Decline despite beat — market reacted to guidance, not numbers. ## 3 Scenarios ### Scenario A · Beat **Q1 EPS > $4.64 + Commercial HVAC ≥ 10%** Threshold: EPS > $4.64^{[FMP est]} and Commercial HVAC ≥ 10%^{[Christopher Kuehn transcript]}. Target: Break above median target $555^{[FMP target]}; high target $585^[FMP] upper bound. ### Scenario B · In-Line **EPS ≈ $4.64 + Commercial HVAC 10-10% + CapEx promise kept** Threshold: EPS ≈ $4.64^{[FMP est]}, Commercial HVAC 10-10%, Q1 CapEx < $79.7M^[FMP]. Target: Consolidation in the band between current $472^[FMP] and median $555^[FMP]. ### Scenario C · Miss **EPS < $4.50 or Commercial HVAC < 35% or CapEx ≥ $79.7M** Threshold: EPS < $4.50^{[FMP est×0.97]} or Commercial HVAC < 35%^{[Christopher Kuehn guidance lower minus 2]}. Target: Current $472 below SMA200 $440^[FMP], if rejection continues, $374^[derived] support activates. ## Risk Notes ### Primary segment below threshold Q2: EPS $4.31 vs $4.27 beat^[FMP], stock +3.3% D+1^[FMP]. Christopher Kuehn Q2 transcript: "For the third quarter, we expect organic revenue growth of approximately 10% and with adjusted EPS of approximately $4.70."^{[Christopher Kuehn]}. ### Backlog concentration No RPO/backlog concentration disclosed in Q2 earnings call. ### Insider trading Form 4 data is marked in the table — this page does not generate assumptions for this stock. | Executive | Action | Amount | Date | |---|---|---|---| **Net:** — (0 transactions · 0 sells · 0 buys) · Q2 FY26 ### CapEx shock Q2 CapEx $79.7M^{[FMP cashflow]}. Q2 op margin 19.3%^{[FMP op margin]} — this level in Q1 is sensitive to CapEx revision risk. ## Wall Street Consensus - **Median target:** $555 (+17.5% upside vs current $472) - **High / Low:** $585 / $475 - **Buy / Hold / Sell:** 13 / 11 / 0 - **Analyst count:** 2 (last quarter), 60 all-time ## Additional Transcript Insights ### 1. record_backlog_visibility **Claim:** The company expects accelerating revenue in the second half of 2026 and a strong foundation for 2027 and beyond, with a record backlog of $12.1 billion, up 70%, and $6 billion slated for future years. **Evidence (transcript):** "Enterprise organic bookings were up 37%, driving record backlog of $12.1 billion, up 70% year-over-year. Our exceptional bookings, record backlog and healthy pipeline provides strong visibility to accelerating revenue in the second half. Our historic backlog also lays a strong foundation for continued market outperformance in the future. with approximately $6 billion slated for 2027 and beyond." **Numbers:** 37%, $12.1 billion, 70%, $6 billion, 2027 ### 2. commercial_hvac_growth **Claim:** Americas Commercial HVAC bookings reached an all-time high, up 50% year-over-year, with broad-based growth across 11 of 14 verticals, including double-digit growth in most of them, beyond just data centers. **Evidence (transcript):** "Our commercial HVAC businesses delivered outstanding performance, particularly in the Americas, where bookings reached an all-time high up 50% year-over-year. ... we track 14 different verticals. They were all very strong. They were all up in fact, they were all of them up over 20%. But it's probably more constructive to look year-to-date -- and year-to-date, we had growth in 11 of 14 verticals from an order standpoint. And most of those 11 were double-digit growth." **Numbers:** 50%, 14, 20%, 11, 14 ### 3. full_year_guidance_raise **Claim:** The company is raising its full year organic revenue growth outlook to approximately 9% and adjusted EPS guidance to a range of $15.20 to $15.30, reflecting strong execution and market dynamics. **Evidence (transcript):** "For the full year, we are again raising our guidance. This reflects the market dynamics and investment priorities we've discussed and consistent strong execution of our value creation flywheel. We are increasing our full year organic revenue growth outlook to approximately 9% and our adjusted EPS guidance to a range of $15.20 to $15.30." **Numbers:** 9%, $15.20, $15.30 ### 4. capital_allocation_capex **Claim:** Trane Technologies maintains a balanced capital allocation strategy with a target deployment of $2.8 billion to $3.3 billion for 2026, which includes expected CapEx of 2% to 3% of revenue. **Evidence (transcript):** "We remain on track with our balanced capital allocation strategy with a target deployment of $2.8 billion to $3.3 billion for the year. ... We continue to pursue disciplined M&A and are strategically investing in capacity to support future growth. with expected CapEx of 2% to 3% of revenue in 2026." **Numbers:** $2.8 billion, $3.3 billion, 2%, 3%, 2026 ### 5. americas_transport_recovery **Claim:** The Americas transport market is expected to improve in late 2026, leading into a multiyear up cycle, transitioning from a headwind to a healthy growth contributor for the company's portfolio. **Evidence (transcript):** "Following a prolonged downturn, we see the Americas transport market improving in late 2026 leading into a multiyear up cycle. Our internal outlook is directionally aligned with ACT, but assumes a more gradual slope of recovery. This reflects a more realistic pace for trailer OEMs to ramp capacity, a dynamic that has historically extended the duration of the up cycle. Having managed the down cycle effectively, while outperforming the markets. We look forward to this business transitioning from a headwind to a healthy growth contributor for our portfolio." **Numbers:** 2026 ### 6. capacity_supply_chain **Claim:** The company has expanded its applied capacity 4x over the last 3 years and continues brick-and-mortar investments to meet increasing demand, actively managing supply chain constraints through robust processes and partner collaboration. **Evidence (transcript):** "Look, we have about $6 billion of the backlog, that's for 2027, as I said earlier. So that's going to give us a lot of momentum going into next year. We're not turning away orders, okay? We kind of I think I mentioned probably 2 quarters ago, we've expanded our applied capacity 4x over the last 3 years. That expansion continues to happen. So we have several -- first of all, we deploy our lean principles. So we're always looking to do more with what we have. But with that said, we also have brick-and-mortar investments that we're making -- we talked about Scalar already. We also have in Grand Rapids, we're making some investments. So look, that's going to continue. We're in front of that. So I feel like we're in a good spot there from a -- do we have enough capacity for the orders that are out there. And bring on if you have any orders and then just bring them out." **Numbers:** $6 billion, 2027, 4x, 3 --- *Data source: FMP (live query, 2026-08-05), Q2 FY2026 earnings call transcript (Translated to EN with Gemini 2.0 Flash). Educational tool, not investment advice.*